Development of an Integrated Continuous Manufacturing Process for the rVSV-Vectored SARS-CoV-2 Candidate Vaccine

The administration of viral vectored vaccines remains one of the most effective ways to respond to the ongoing novel coronavirus disease 2019 (COVID-19) pandemic. However, pre-existing immunity to the viral vector hinders its potency, resulting in a limited choice of viral vectors. Moreover, the bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zeyu, Paes, Barbara Cristina Martins Fernandes, Fulber, Julia Puppin Chaves, Tran, Michelle Yen, Farnós, Omar, Kamen, Amine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143285/
https://www.ncbi.nlm.nih.gov/pubmed/37112753
http://dx.doi.org/10.3390/vaccines11040841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143285/
https://www.ncbi.nlm.nih.gov/pubmed/37112753
http://dx.doi.org/10.3390/vaccines11040841

Ejemplares similares